RNXT
Closed
Renovorx Inc
1.27
-0.05 (-3.80%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.315
Day's Range: 1.27 - 1.33
Send
sign up or login to leave a comment!
When Written:
2.81
RenovoRx Inc is a medical technology company that develops innovative solutions for the treatment of cancer. The company is based in Los Altos, California, and was founded in 2010 by Dr. Shaun Bagai and Dr. Ramtin Agah. RenovoRx's flagship product is the RenovoCath Delivery System, which is a minimally invasive device used to deliver chemotherapy directly to tumors. The device is designed to improve the effectiveness of chemotherapy while minimizing side effects. RenovoRx has received FDA clearance for the RenovoCath Delivery System and is currently conducting clinical trials to evaluate its safety and efficacy. The company is also developing other products and technologies for the treatment of cancer, including targeted drug delivery systems and imaging technologies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








